![Toby Eyre: Important primary analysis of UK MCL biobank at EHA2024](https://oncodaily.com/pub/uploads/2023/12/Toby-Eyre-e1701716668459.jpg)
Photo taken from Toby Eyre/X
May 18, 2024, 04:13
Toby Eyre: Important primary analysis of UK MCL biobank at EHA2024
Toby Eyre, CLL specialist at Oxford University Hospitals, shared on X:
“Look out for important primary analysis of UK MCL biobank at EHA2024.
Mant et al N=588, Active observation in 38% (N=222) of prospectively identified MCL patients.
Delaying initiation of treatment in indolent Mantel Cell Lymphoma does not worsen survival outcomes versus immediate treatment.
Valid management strategy.”
Source: Toby Eyre/X
Jul 1, 2024, 03:08